This paper reports on the British findings from a cross-national study
of HIV prevalence and HIV risk behaviour among 1,037 injecting drug u
sers (IDUs) recruited from a variety of treatment- and community-based
settings during 1990. Confirmed HIV saliva test results show 12.8% (6
3) of London respondents and 1.8% (8) of Glasgow respondents to be HIV
antibody positive. Among London respondents, a higher rate of prevale
nce was found in those with no experience of drug treatment. A greater
proportion of Glasgow respondents (68%) than London respondents (47%)
reported sharing used injecting equipment in the 6 months prior to in
terview. The majority (88% in both cities) attempted cleaning borrowed
equipment, although less than a third (31 % in London and 30% in Glas
gow) usually used bleach. The majority of respondents (71 % in London
and 82% in Glasgow) were sexually active with partners of the opposite
sex in the last 6 months, and respondents had a mean number of 2.4 no
n-commercial sexual partners in London and 2.1 in Glasgow. Levels of r
eported condom use were comparable with reports in the heterosexual po
pulation as a whole, with 70% of London respondents and 75% of Glasgow
respondents never using condoms with primary partners, and 34% of Lon
don and 52% of Glasgow respondents never using condoms with casual par
tners. Half (48%) of London respondents and 42% of Glasgow respondents
reported sexual intercourse with non-injecting private sexual partner
s, while 14% of female respondents in London and 22% in Glasgow had en
gaged in prostitution. Levels of risk-taking in each of the two cities
indicate the potential for further transmission of HIV among drug inj
ectors, and their sexual and sharing partners.